Active not recruiting × Observational × Plasma cell × Clear all National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
RHUMM
Active not recruiting
180 enrolled
TEC-CARE
Active not recruiting
200 enrolled
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Active not recruiting
656 enrolled
MUST
Active not recruiting
250 enrolled
Agriculture Health Study
Active not recruiting
89,655 enrolled
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Active not recruiting
69 enrolled
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
Active not recruiting
49 enrolled
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
Active not recruiting
192 enrolled
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
Active not recruiting
50 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
SEATTLE
Active not recruiting
75 enrolled
A Study of NINLARO® in Chinese Adults With Multiple Myeloma
Active not recruiting
72 enrolled
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Active not recruiting
2,555 enrolled
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
Active not recruiting
911 enrolled
Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
Active not recruiting
150 enrolled
PNRR-2022-1237
Active not recruiting
60 enrolled
Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Active not recruiting
1 enrolled
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
Active not recruiting
350 enrolled
Biomarker for Infection Risk in CLL and MM
Active not recruiting
150 enrolled
Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma
Active not recruiting
200 enrolled
LEADER
Active not recruiting
357 enrolled
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Active not recruiting
250 enrolled
M4
Active not recruiting
96 enrolled
IONA-MM
Active not recruiting
583 enrolled
CLARITY
Active not recruiting
530 enrolled
MMRF Molecular Profiling Protocol
Active not recruiting
1,000 enrolled
Selinexor
Active not recruiting
20 enrolled
OxPLoreD
Active not recruiting
574 enrolled
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active not recruiting
9,000 enrolled
COSMIC
Active not recruiting
200 enrolled
HemaTMA
Active not recruiting
5,000 enrolled
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
Active not recruiting
1,000 enrolled
ABE-DESCART
Active not recruiting
350 enrolled